Now I have all the information needed. Let me synthesize the reviews against the paper and produce the final authoritative review.

---

## Summary

This paper proposes an end-to-end framework for multi-view diabetic retinopathy (DR) grading that reduces dependence on costly external annotations. The core idea is to generate lesion proposals on-the-fly via a Grade-Activated Lesion Proposal (GALP) module — which uses stage-wise CAMs conditioned on auxiliary grade classifiers — and then fuse these proposals across views using a Cross-View Lesion Expert Guided Regional Fusion (LGRF) module with dynamic MoE routing and Top-K weighted cross-view attention. Experiments on two multi-view DR benchmarks (MFIDDR and DRTiD) show the method matches or surpasses externally-informed methods without requiring any external annotations.

## Strengths

- **Strong empirical performance without external annotations**: On MFIDDR, the method achieves 83.9% accuracy without external cues, surpassing all end-to-end baselines (e.g., ETMC at 81.5%) and several externally-informed methods (e.g., CVSA with vessel masks at 82.6%). On DRTiD, it achieves 76.0% accuracy, outperforming CrossFiT (75.6%) which uses OD/macular coordinates. These are concrete, verifiable results on standard benchmarks.

- **Creative architectural integration**: The combination of stage-wise auxiliary CAM-based proposal generation with gated MoE cross-view fusion (LGRF) is a non-trivial integration of established techniques (CAMs, MoE, cross-attention) into a coherent pipeline for multi-view medical image classification. The idea of using the current view to gate which experts process adjacent-view proposals is genuinely interesting.

- **Clean ablation analysis**: Table 4 isolates GALP, LGRF, and expert routing, showing each component contributes measurable gains (e.g., removing LGRF drops accuracy from 83.9% to 82.3%). The hyperparameter study (Figure 3) provides empirical grounding for the retention ratio and expert count choices, making the design decisions transparent.

- **Grade-wise performance analysis**: Table 2 shows the self-derived variant achieves strong F1 on clinically important moderate/severe grades (Grade 3 F1=74.1% without external cues), indicating sensitivity to disease-relevant features across the severity spectrum.

## Weaknesses

### Fatal

None. The core empirical contribution — that self-derived proposal-based fusion improves multi-view DR grading without external annotations — is supported by the experiments, and the flaws below do not invalidate this.

### Major

- **Missing equal-backbone baseline**: The paper uses Swin-B as its backbone but compares against end-to-end methods that use weaker backbones (ResNet, VGG, CNNs). There is no Swin-B + simple multi-view fusion baseline (e.g., concatenated GAP-pooled features from all views, or vanilla cross-attention across all view tokens without GALP/LGRF). This makes it difficult to determine how much of the 83.9% accuracy is due to the backbone versus the proposed modules. The 2.4% gap over the next best end-to-end method (ETMC, 81.5%) may partially reflect backbone differences.

- **"Lesion proposal" labeling is unvalidated**: The paper's narrative rests heavily on the framing that GALP produces *lesion* proposals. In reality, GALP produces grade-conditioned CAM-based region selections. The assumption that "regions with higher activation are more likely to contain lesion evidence" (line 153) is reasonable but never verified. The MFIDDR dataset provides lesion segmentation masks; the paper could have computed overlap metrics or shown qualitative overlays. Without this, calling them "lesion proposals" rather than "discriminative region proposals" is an overclaim that affects the interpretability narrative (though it does not undermine the quantitative grading results). The claim of "superior robustness and interpretability" (contribution 2) is unsupported by any interpretability evaluation.

### Minor

- **No statistical error reporting**: Tables 1–4 report single-point estimates without confidence intervals, standard deviations, or significance tests. The margins between the proposed method and the best externally-informed methods are small (e.g., 83.9% vs. 84.2% on MFIDDR). While single-run evaluation on fixed splits is common in this subfield, reporting variance across seeds would strengthen the reliability of the SOTA claims.

- **GALP ablation conflates two mechanisms**: The "w/o GALP" condition (Table 4) removes both the auxiliary classification loss and the Top-K proposal selection simultaneously. The individual contributions of auxiliary supervision versus proposal filtering cannot be disentangled. A finer-grained ablation (e.g., auxiliary loss only, proposal filtering with no auxiliary loss) would provide clearer insight.

- **Cross-view design choice is under-justified**: LGRF fuses each view only with its cyclic adjacent view (i → i+1). The paper does not discuss why all-pairs fusion was not considered, or whether the cyclic-adjacent design leaves information unused. For the two-view DRTiD dataset this is a non-issue, but for four-view MFIDDR it is a genuine design choice that deserves justification.

### Trivial

- The bold/underline conventions in Table 3 for AUC values are inconsistently applied and confusing.
- Table 2 has empty cells for specificity and precision for several baselines, reducing comparability without explanation.
- The image resizing differs between datasets (224×224 for MFIDDR, 512×512 for DRTiD); while justified by prior work, this choice should be acknowledged when drawing cross-dataset generalizations.

## Nice-to-Haves

- **Proposal-lesion overlap analysis**: Computing IoU/precision-recall between GALP-selected regions and the MFIDDR lesion masks would directly address the "lesion proposal" validation gap.
- **Expert specialization analysis**: Examining whether different MoE experts specialize in particular views, grades, or lesion types would add credibility to the expert routing design.
- **Qualitative overlay visualizations**: Showing GEMs and selected proposals overlaid on fundus images (especially for mild NPDR where microaneurysms matter) would strengthen the paper.

## Removed Points

These points are flagged to be removed; treat them with caution:

- *"RETFound multi-view implementation is not described, making the comparison suspect"* — RETFound at 74.1% is far below all other methods including other end-to-end baselines. The comparison favors the baselines, not the authors. Any ambiguity about its implementation does not undermine the paper's claims. Removed.

- *"The claim that current methods create 'performance ceilings' is asserted without direct evidence"* — This is a framing statement in the introduction, not a tested hypothesis. It's part of the motivation narrative, and the paper provides enough context from prior work to support it. Removed.

- *"Confidence intervals / significance tests are missing"* — I kept this as a minor weakness but note that single-run evaluation on fixed benchmarks is standard in this subfield. The harsh critic's framing of this as a major evidential gap is overstated. Downgraded to minor.

- *"Cross-dataset generalization claims confounded by different image resolutions"* — The paper does not make strong cross-dataset generalization claims; it evaluates separately on each dataset using the resolutions standard for those benchmarks. Removed.

- *"The hyperparameter sweeps are performed only on MFIDDR"* — While replicating on DRTiD would be nice, this is a resource constraint common to most papers. Moved to Nice-to-Haves rather than a weakness.

- *"Paper should investigate performance under missing views"* — This is explicitly outside the paper's scope. The paper addresses annotation reduction, not view-robustness. Removed.

## Novel Insights

The most interesting novel observation from synthesizing these reviews is that the paper occupies a clever middle ground between two camps in medical image analysis: purely end-to-end models (which avoid annotation burden but struggle with fine-grained lesions) and externally-informed models (which use lesion/vessel annotations but are expensive). By generating grade-discriminative proposals *within* the training pipeline via CAMs, the paper effectively bootstraps lesion-aware cues without needing them at inference time. The insight that auxiliary grade classifiers can double as a mechanism for producing useful spatial proposals — rather than just intermediate supervision — is a transferable idea that could generalize beyond DR to other medical imaging tasks where pathology is localized and grade-dependent.

## Suggestions

- The most impactful improvement would be to add a Swin-B + simple multi-view fusion baseline (e.g., concatenated GAP features, or all-to-all cross-attention). This would cleanly separate backbone effects from module effects and significantly strengthen the paper.
- Consider tempering the "lesion proposals" terminology to "discriminative region proposals" or "grade-evidence regions," or alternatively, provide at least qualitative evidence (overlays of GEMs on fundus images with lesion ground truth) that the proposals capture lesion-relevant areas.
- Report results over 3+ random seeds with mean ± std for the main comparison tables.

## Score and Decision

**Anchor comparison:**

| Anchor | Path | Avg Score | Comparison |
|---|---|---|---|
| ProConMV (multi-view DR, concept reasoning) | `/home/wg25r/review_agent/human_reviews_2026/9gc58FeBba.md` | 5.00 | ProConMV had similar DR focus but relied on synthetic GPT-generated text and had conflicting interpretability claims. Current paper has stronger empirical results and a cleaner story. |
| KCCL (DR grading, concept learning) | `/home/wg25r/review_agent/human_reviews_2026/WuEE1f4NId.md` | 4.00 | KCCL had weak overall accuracy (F1=47.8) and was criticized as incremental. Current paper has much stronger accuracy numbers and a more novel architectural contribution. |
| M³Ret (multi-retinal disease dataset) | `/home/wg25r/review_agent/human_reviews_2026/QCCMvWYwPN.md` | 4.50 | M³Ret was a dataset paper with limited novelty. Current paper has more methodological novelty and stronger benchmarking. |
| LTH (label transfer, medical imaging) | `/home/wg25r/review_agent/human_reviews_2026/cESVZ0SfjA.md` | 1.50 | LTH had essentially no theoretical content despite claiming a "theoretical framework." Current paper is far stronger across all dimensions. |
| Semantic Robustness (retinal imaging) | `/home/wg25r/review_agent/human_reviews_2026/mkoeblmWvN.md` | 2.67 | Very narrow scope, presentation issues. Current paper is substantially more substantive. |
| D²4FAD (few-shot anomaly detection) | `/home/wg25r/review_agent/human_reviews_2026/tRO6G20Qba.md` | 5.00 | D²4FAD was accepted as poster with a clean method and thorough experiments. Current paper has comparable novelty and empirical strength, but weaker validation of its central "lesion" framing. |

The current paper has real contributions: a novel architectural combination, strong empirical results beating annotation-dependent methods without annotations, and solid ablations. The unvalidated lesion-proposal framing and missing equal-backbone baseline prevent it from being a clear accept, but do not negate the genuine empirical contribution. It sits at the accept-poster borderline, comparable to the D²4FAD and ProConMV anchors.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>